Samalin Investment Counsel, LLC Moderna, Inc. Transaction History

Samalin Investment Counsel, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $11,713 - $17,659	-100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $2,276 - $4,230	18 Added 21.95%	100 $17.2 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $3,994 - $8,720	-18 Reduced 18.0%	82 $31.6 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $12,991 - $23,498	100 New	100 $23,000
Q1 2021 May 11, 2021	SELL	$109.18 - $185.98 $5,459 - $9,299	-50 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$54.34 - $94.85 $2,717 - $4,742	50 New	50 $3,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.